0
OnSite™ HSV-1 IgG/IgM Rapid Test Kit, CE, 30 Tests
Catalog No :
CAS Number :
Brand :
In Stock
Specifications:
| Application | Diagnostic Testing | ||
| Storage Temperature | Room Temperature | ||
| Product Type | Test Kit | Forms | Kit with Various components |
| Product Brand | CTK Biotech | ||
| Product Grade | Medical grade | ||
The OnSite HSV-1 IgG/IgM Rapid Test CE is a lateral flow chromatographic immunoassay designed for the qualitative detection and differentiation of IgG and IgM antibodies to Herpes Simplex Virus type 1 (HSV-1) in human serum, plasma, or whole blood. By utilizing glycoprotein G1, a type-specific antigen, this test ensures accurate detection of HSV-1 antibodies, providing clinicians with reliable diagnostic support at the point of care.
Key Features
- Type-specific detection using HSV-1 glycoprotein G1.
- Differentiates between IgG and IgM antibodies to HSV-1.
- High agreement with ELISA: 90.7% for IgG and 85.0% for IgM.
- Multiple specimen compatibility: serum, plasma, or whole blood.
- Requires only a small sample volume (10 µL), enabling multiple tests per specimen.
- Rapid results in 10 minutes, facilitating immediate clinical action.
- Long shelf life (24 months at 2–30°C) and easy transport.
Kit Contents
Each kit (30 tests) contains:
- One cassette device (per pouch).
- One desiccant.
- Capillary tubes (10 µL).
- Sample diluent (REF SB-R0203, 5 mL/bottle).
- Package insert (instructions for use).
Specifications
| Parameter | Details |
|---|---|
| Product Name | HSV-1 IgG/IgM Rapid Test CE |
| Catalog Number | R0203C |
| Format | 30 tests/kit |
| Specimen Type | Serum (S), Plasma (P), Whole Blood (WB) |
| Detection | IgG and IgM antibodies to HSV-1 |
| Principle | Lateral Flow Chromatographic Immunoassay |
| Antigen Used | Glycoprotein G1 (type-specific) |
| Agreement with ELISA | 90.7% (IgG), 85.0% (IgM) |
| Sample Volume | 10 µL |
| Turnaround Time | 10 minutes |
| Storage | 2–30°C, 24 months |
| Regulatory Status | CE-marked |
Applications
- Rapid detection of HSV-1 infections.
- Differentiation of IgG and IgM antibodies to distinguish acute vs. past infection.
- Clinical use in hospitals, diagnostic labs, and sexual health clinics.
- Point-of-care testing for immediate treatment decisions.
- Epidemiological surveillance of HSV-1 prevalence.
The OnSite HSV-1 IgG/IgM Rapid Test CE offers a fast, accurate, and type-specific solution for detecting and differentiating HSV-1 antibodies. By combining glycoprotein G1 specificity, rapid results, and high agreement with ELISA, this CE-marked rapid test is a dependable diagnostic tool for both clinical care and public health surveillance. Its small sample requirement, flexible specimen types, and ease of use make it highly suitable for point-of-care testing in diverse healthcare settings.